Development of cardiac hypertrophy in rats exposed to acute hypobaric hypoxia. - Studies with protein synthesis inhibitors.
The study is based on the experimental model of myocardial hypertrophy in rats. Male Sprague-Dawley adult rats were exposed to acute hypoxia in a hypobaric chamber (0.40 atmospheres of air for 24 hours). Myocardial hypertrophy was detected by wet and dry heart weight values when calculated on the basis of total body weight; i.e., ratio heart weight in mg to body weight in 100 g. The behaviour of myocardial hypertrophy was assessed after treatment of intact animals with Puromycin (10 mg/rat i.p.) or Actinomycin-D (100 micrograms/rat i.p.). The experimental results showed the following dry heart weight values (mean +/- SEM): room pressure 60.5 +/- 1.5; hypoxia 69.2 +/- 0.9; Actinomycin-D + hypoxia 63.5 +/- 0.6; Puromycin + hypoxia 62.4 +/- 1.5, (P less than 0.001). From the comparison of data reveals that inhibitors of protein synthesis completely inhibit the myocardial hypertrophy due to hypoxia. Thus it is documented that acute hypobaric hypoxia is able to induce in the rat an actual myocardial hypertrophy condition as expressed of the enhanced protein synthesis.
D000818:Animals; D001274:Atmospheric Pressure; D001835:Body Weight; D006332:Cardiomegaly / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D003609:Dactinomycin / Q000627:therapeutic use*; D004195:Disease Models, Animal; D000860:Hypoxia / Q000150:complications*; D008297:Male; D009206:Myocardium / Q000473:pathology; D009929:Organ Size; D011691:Puromycin / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D003609:Dactinomycin; D011691:Puromycin